Clinical research - Press Releases

Date	Title	Company
30-Apr-2025	Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders	Boehringer Ingelheim
30-Apr-2025	GSK makes strong start to 2025 with growth in sales, profits and earnings	GSK
30-Apr-2025	Nouscom Presents Positive Final Results from Completed Phase Ib/II Study of Neoantigen Immunotherapy NOUS-209 at AACR 2025, Demonstrating a Highly Potent and Durable Immune Response in Lynch Syndrome Carriers	Nouscom
30-Apr-2025	Microbiotica reveals novel mechanisms showing how the microbiome can improve immunotherapy response based on MB097, a clinical-stage drug candidate being evaluated in combination with KEYTRUDA® (pembrolizumab) in patients with advanced melanoma	Microbiotica
25-Apr-2025	Olympus Appoints New CEO - Names Bob White Representative Executive Officer, President, Chief Executive Officer and a new Director candidate	Olympus Corporation
24-Apr-2025	Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025	Heidelberg Pharma AG
24-Apr-2025	OXB Named Among UK’s Best Employers by Financial Times in 2025	OXB
24-Apr-2025	Bioxodes announces positive Phase 2a interim data for BIOX-101 in intracerebral hemorrhagic stroke patients	Bioxodes
24-Apr-2025	Mosaic Therapeutics in-licences two clinical-stage assets from Astex Pharmaceuticals	Syncona Limited
24-Apr-2025	HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025	HUTCHMED
24-Apr-2025	Hikma reiterates full year guidance following good start to the year	Hikma
24-Apr-2025	NEW IQVIA INSTITUTE REPORT WARNS OF ACCESS DISPARITIES FOR CAR T-CELL THERAPY ACROSS EUROPE	IQVIA
24-Apr-2025	The UK’s HIV Response is Failing Women – A New Movement Calls for Change	akt health a JPA Health company
24-Apr-2025	Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS	Pharming
24-Apr-2025	Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancers	Boehringer Ingelheim
24-Apr-2025	Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Greater San Diego to Help Accelerate Cell Therapy Development	Thermo Fisher Scientific
24-Apr-2025	Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria	Regeneron Investor Relations
24-Apr-2025	Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research	Debiopharm
24-Apr-2025	Symbiosis Earns Recognition from EcoVadis for Commitment to Sustainability	Symbiosis
24-Apr-2025	Transgene to Provide Updated Phase I Data in a Rapid Oral Presentation on Individualized Therapeutic Cancer Vaccine TG4050 at ASCO 2025	Transgene